Peter M Pushko

This inventor holds 58 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Vaccine Development (CPC class C12N). Top assignees: Novavax, Inc., US Government as Represented by the Secretary of the Army, Medigen, Inc.. Active years: 1998-2026.

USPTO Granted Patents = 58 (Patent Applications = 8)

% Patents Active = 91.4

CIPO Patents = 3

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 16

Forward Citations = 704(Granted Patents)

Forward Citations (Not Self Cited) = 498(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rockville, MD (US) (2011 - 2019)
Gaithersburg, MD (US) (2017 - 2020)
Frederick, MD (US) (1998 - 2024)

Company Filing History:

US Government as Represented by the Secretary of the Army

The University of North Carolina at Chapel Hill

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Vaccine

RSV F Proteins

Influenza Virus-Like Particles

DNA Vaccines

Virus-Like Particles

Chikungunya Virus

Adjuvants

Spike Protein

Immunogens

Infectious Diseases

Protein Engineering

Viral Proteins

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12589146 - ADJUVANTED PROTEIN VACCINES COMPRISING MODIFIED FULL-LENGTH SPIKE PROTEIN OF SARS-COV-2 COMPOSITION AND METHODS OF USE (2026-03-31),

2. 12357684 - Modified RSV F proteins and methods of their use (2025-07-15),

3. 12303560 - Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus (2025-05-20),

4. 11911461 - Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use (2024-02-27),

5. 11576965 - Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens (2023-02-14),

6. 11446374 - Modified RSV F proteins and methods of their use (2022-09-20),

7. 11058759 - Vaccines against infectious diseases caused by positive stranded RNA viruses (2021-07-13),

8. 11052146 - Modified RSV F proteins and methods of their use (2021-07-06),

9. 10729760 - Functional influenza virus like particles (VLPs) (2020-08-04),

10. 10653769 - iDNA vaccines and methods for using the same (2020-05-19),

11. 10548968 - Functional influenza virus-like particles (VLPS) (2020-02-04),

12. 10544399 - Highly efficient influenza matrix (M1) proteins (2020-01-28),

13. 10188723 - Functional influenza virus like particles (VLPs) (2019-01-29),

14. 10022437 - Modified RSV F proteins and methods of their use (2018-07-17),

15. 9968672 - IDNA vaccines and methods for using the same (2018-05-15),

Title: Peter M Pushko: Innovator in Vaccine Development

Introduction

Peter M Pushko is a prominent inventor based in Frederick, MD, renowned for his significant contributions to the field of immunology. With an impressive portfolio of 54 patents, he has made advancements that impact vaccine development and disease prevention.

Latest Patents

Among his latest innovations are two notable patents:

- **Recombinant Bovine Immunodeficiency Virus Gag Virus-Like Particles Containing Influenza Immunogens**: This patent describes the development of recombinant virus-like particles (VLPs) from bovine immunodeficiency virus gag protein, incorporating various target pathogen proteins. The invention includes compositions featuring the Bgag VLPs alongside methods for their production and application.

- **Modified RSV F Proteins and Methods of Their Use**: This invention pertains to modified or mutated respiratory syncytial virus (RSV) fusion proteins. It outlines methods for creating these proteins, which are intended for use in immunogenic compositions such as vaccines aimed at treating and preventing RSV infections.

Career Highlights

Peter has an impressive background with significant associations in his career, particularly with Novavax, Inc. and the United States of America as represented by the Secretary of the Army. His experience in these organizations allowed him to develop groundbreaking technologies that could improve public health.

Collaborations

Peter has collaborated with numerous professionals throughout his career, including notable colleagues such as Gale Smith and Jonathan F Smith. These collaborations have further enhanced the effectiveness and scope of his innovations.

Conclusion

Peter M Pushko stands out as an inventor whose work in vaccine development showcases his commitment to enhancing healthcare solutions. With his extensive patent portfolio and fruitful collaborations, he continues to contribute to significant advancements in medical technology.